BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7615577)

  • 1. Corynanthine inhibits, while idazoxan potentiates, cardiotoxic effects of ouabain.
    Thomas GP
    J Auton Pharmacol; 1995 Apr; 15(2):85-91. PubMed ID: 7615577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the protective effect of azepexole on ouabain-induced cardiac arrhythmias and lethality in guinea-pig.
    Thomas GP
    Eur J Pharmacol; 1995 Apr; 276(3):215-21. PubMed ID: 7541362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of flutonidine on ouabain-induced arrhythmias and lethality in guinea-pig.
    Thomas GP; Varma RK
    Pharmacol Res; 1993; 27(4):365-71. PubMed ID: 8103597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alpha-adrenoceptor agonists and antagonists on ouabain-induced arrhythmias and cardiac arrest in guinea-pig.
    Thomas GP; Tripathi RM
    Br J Pharmacol; 1986 Oct; 89(2):385-8. PubMed ID: 2877699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective action of clonidine against the arrhythmogenic and lethal effects of ouabain in guinea-pigs.
    Thomas GP; Stephen PM
    Br J Pharmacol; 1991 Dec; 104(4):995-9. PubMed ID: 1687372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC; Roach AG; Strachan DA; Virdee NK
    Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of B-HT 920 on cardiotoxic effects of ouabain in guinea pigs.
    Thomas GP; Kaushal R; Tripathi RM
    Indian J Exp Biol; 1991 Nov; 29(11):1084-6. PubMed ID: 1687739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alpha adrenoceptor antagonist properties of idazoxan in normal subjects.
    Elliott HL; Jones CR; Vincent J; Lawrie CB; Reid JL
    Clin Pharmacol Ther; 1984 Aug; 36(2):190-6. PubMed ID: 6146423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of idazoxan, prazosin, and yohimbine on coronary ligation-induced arrhythmias in spontaneously hypertensive rats.
    Roegel JC; De Jong W; Monassier L; Feldman J; Bousquet P
    J Cardiovasc Pharmacol; 1996 Feb; 27(2):226-34. PubMed ID: 8720421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between the autonomic nervous system and the cardiovascular effects of ouabain in guinea-pigs.
    Lechat P; Schmitt H
    Eur J Pharmacol; 1982 Feb; 78(1):21-32. PubMed ID: 6122584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of yohimbine, WY 26392 and idazoxan on sympathetic nerve activity.
    Ramage AG; Tomlinson A
    Eur J Pharmacol; 1985 Feb; 109(2):153-60. PubMed ID: 2859996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective action of cimetidine against ouabain-induced pressor effects, arrhythmias, and lethality in guinea pigs.
    Trzeciakowski JP
    J Cardiovasc Pharmacol; 1985; 7(4):622-9. PubMed ID: 2410699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine.
    Doxey JC; Lane AC; Roach AG; Virdee NK
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Feb; 325(2):136-44. PubMed ID: 6144048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of yohimbine and idazoxan on the systemic and regional hemodynamics of waking rats].
    Ivashev MN; Medvedev OS; Giulumian AD
    Farmakol Toksikol; 1991; 54(5):20-2. PubMed ID: 1686868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor and cardiovascular effects of selective alpha 2-adrenoceptor antagonists in the decerebrated rabbit.
    Harris J; Clarke RW
    Eur J Pharmacol; 1993 Jun; 237(2-3):323-8. PubMed ID: 8103464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of beta 2-adrenoceptor-mediated mechanisms in the cardiovascular responses to alpha 1- and alpha 2-adrenoceptor antagonism in conscious, unrestrained, Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T
    Br J Pharmacol; 1988 Jan; 93(1):9-22. PubMed ID: 2894880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing central autonomic actions of alpha 1- and alpha 2-adrenoceptor antagonists on oculomotor tone.
    Hey JA; Koss MC
    Eur J Pharmacol; 1987 Jul; 139(2):243-6. PubMed ID: 2888668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GYKI-12743 a new postsynaptic vascular alpha-adrenoceptor antagonist.
    Rabloczky G; Jaszlits L; Horváth E
    Acta Physiol Hung; 1991; 77(3-4):257-67. PubMed ID: 1684485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible involvement of presynaptic alpha 1-adrenoceptors in the effects of idazoxan and prazosin on 3H-noradrenaline release from tail arteries of SHR.
    Hicks PE; Najar M; Vidal M; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):354-61. PubMed ID: 2877400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.